Delivery Order SPE2DB24D1205-SPE2DB25FCRKH

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,915.26 Firm Fixed Price Delivery Order is for the supply of 4567089257 - ONDANSETRON ODT 8 MG TABLET 30S, with a completion date of January 30, 2025. The contract is not associated with any set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,017.87 firm fixed price delivery order is for the supply of 4566306125 ONDANSETRON ODT 8 MG TABLET 30S, with a completion date of November 4, 2024. This award is not associated with a set-aside program. Additionally, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,973.32, is a delivery order for the provision of 4567052687 ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,364.35, is a Firm Fixed Price Delivery Order for the supply of 4567201817 ! ONDANSETRON ODT 8 MG TABLET 30S. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,686.98, is a delivery order for the supply of 4564882367 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,598.33 firm fixed price delivery order is for the provision of 4567555597 ! ONDANSETRON ODT 8 MG TABLET 30S, with a performance period through March 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,551.02 firm fixed-price delivery order is for the supply of 4567458155 ! ONDANSETRON ODT 8 MG TABLET 30S, with a performance period running through March 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,306.95 firm fixed-price delivery order covers the supply of 4566565172 ONDANSETRON ODT 8 MG TABLET 30S, with a period of performance through November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,251.99 firm fixed-price delivery order is for the supply of 4567063170 - ONDANSETRON ODT 8 MG TABLET 30S. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, demonstrates the company's role in supplying critical medical products to the U.S. government. The $5,822.41 delivery order, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the procurement of 4,566,361,768 units of the generic drug Ondansetron ODT 8 mg tablets. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCRKH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,330.20 firm fixed-price delivery order is for the supply of 4566343373 ONDANSETRON ODT 8 MG TABLET 30S. The award is not designated as a set-aside contract.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/20/25, 2:16 PM